[[ Whitepaper ]] Connecting With Rare Disease Patient Communities: Patient Advocates laureng Whitepapers April 19, 2018
Choosing the Right Channel Strategy for Specialty Product Success Karina Kusova Clinical Development, Market Access, Orphan Drug Congress, Supply Chain & Manufacturing, Uncategorized, Whitepapers May 3, 2017
[Whitepaper] Challenging Conventional Patient Recruitment and Care Strategies for Rare Disease Studies Karina Kusova Clinical Development, Orphan Drug Congress, Uncategorized, Whitepapers April 10, 2017
[[whitepaper]] The New Reality: Maximizing Value in Rare Disease Launches Karina Kusova Clinical Development, Featured on App, Orphan Drug Congress, Uncategorized, Whitepapers April 6, 2017
What’s New in Rare Cancer Research? (Spoiler Alert: A Lot!) Karina Kusova Advocacy, Clinical Development, Market Access, Orphan Drug Congress, Orphan Drugs Live October 10, 2016
View Post Constructive, Critical, Creative: Revealing The Content of the World Orphan Drug Congress 2014 In Orphan Drug Congress by Hugh BlackstaffeApril 8, 2014Leave a Comment Oh Ladies and Gentlemen, I cannot express just how excited I am to be able to write this blog post. It’s been over a week …